Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 137.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.00p
  • 52 Week Low: 102.50p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 11,653
  • Market Cap: 146.07m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
26.29% above the market average26.29% above the market average26.29% above the market average26.29% above the market average26.29% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
1yr Revenue Growth
54.38% below the market average54.38% below the market average54.38% below the market average54.38% below the market average54.38% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
15.4% below the market average15.4% below the market average15.4% below the market average15.4% below the market average15.4% below the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
1yr DPS Growth
10.19% above the market average10.19% above the market average10.19% above the market average10.19% above the market average10.19% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.72% below the market average55.72% below the market average55.72% below the market average55.72% below the market average55.72% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Price Book Ratio
23.39% below the market average23.39% below the market average23.39% below the market average23.39% below the market average23.39% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
27.43% above the market average27.43% above the market average27.43% above the market average27.43% above the market average27.43% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Price Chg 3m
25.57% above the market average25.57% above the market average25.57% above the market average25.57% above the market average25.57% above the market average
10% below the sector average10% below the sector average10% below the sector average10% below the sector average10% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
16.71% above the market average16.71% above the market average16.71% above the market average16.71% above the market average16.71% above the market average
12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average
Momentum 20
38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average
48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
16.98% below the market average16.98% below the market average16.98% below the market average16.98% below the market average16.98% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
ROCE
71.71% above the market average71.71% above the market average71.71% above the market average71.71% above the market average71.71% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
22.20% above the market average22.20% above the market average22.20% above the market average22.20% above the market average22.20% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Forecast EPS
45.11% below the market average45.11% below the market average45.11% below the market average45.11% below the market average45.11% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.44% above the market average43.44% above the market average43.44% above the market average43.44% above the market average43.44% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
24.63% above the market average24.63% above the market average24.63% above the market average24.63% above the market average24.63% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
29.90% above the market average29.90% above the market average29.90% above the market average29.90% above the market average29.90% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Cash
6.85% above the market average6.85% above the market average6.85% above the market average6.85% above the market average6.85% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
10.65% above the market average10.65% above the market average10.65% above the market average10.65% above the market average10.65% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Buys 1y
0.52% below the market average0.52% below the market average0.52% below the market average0.52% below the market average0.52% below the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
29.32% above the market average29.32% above the market average29.32% above the market average29.32% above the market average29.32% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Brokers Percent Neutral
90.15% above the market average90.15% above the market average90.15% above the market average90.15% above the market average90.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 137.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.00p
52 Week Low 102.50p
Volume 11,653
Shares Issued 106.23m
Market Cap 146.07m
RiskGrade 129

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.92% below the market average57.92% below the market average57.92% below the market average57.92% below the market average57.92% below the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Trend
60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Income
20.32% above the market average20.32% above the market average20.32% above the market average20.32% above the market average20.32% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
30.69% below the market average30.69% below the market average30.69% below the market average30.69% below the market average30.69% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 24-Jan-2020

Time Volume / Share Price
16:25 400 @ 138.60p
14:59 4,000 @ 136.50p
14:10 13 @ 138.60p
11:03 760 @ 136.16p
09:33 6,480 @ 138.60p

Cello Health Key Personnel

CEO Mark Scott

Top of Page